Accessibility Menu
 
ImExHS logo

ImExHS

(ASX) IME

Current Price$0.40
Market Cap$21.63M
Since IPO (2018)-71%
5 Year-83%
1 Year+14%
1 Month+0%

ImExHS Financials at a Glance

Market Cap

$21.63M

Revenue (TTM)

$55.54M

Net Income (TTM)

$5.51M

EPS (TTM)

$-0.06

P/E Ratio

-6.71

Dividend

$0.00

Beta (Volatility)

0.08 (Low)

Price

$0.40

Volume

12,032

Open

$0.40

Previous Close

$0.40

Daily Range

$0.40 - $0.40

52-Week Range

$0.22 - $0.47

IME News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ImExHS

Industry

Health Care Technology

Employees

290

CEO

Germán Aníbal Arango Bonnet, PhD

Website

imexhs.com

Headquarters

Mascot, NSW 2020, AU

IME Financials

Key Financial Metrics (TTM)

Gross Margin

36%

Operating Margin

0%

Net Income Margin

-10%

Return on Equity

-28%

Return on Capital

0%

Return on Assets

-12%

Earnings Yield

-14.90%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$21.63M

Shares Outstanding

54.07M

Volume

12.03K

Short Interest

0.00%

Avg. Volume

14.32K

Financials (TTM)

Gross Profit

$8.31M

Operating Income

$697.64K

EBITDA

$1.52M

Operating Cash Flow

$564.71K

Capital Expenditure

$320.55K

Free Cash Flow

$244.16K

Cash & ST Invst.

$3.30M

Total Debt

$566.32K

ImExHS Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$15.32M

+41.0%

Gross Profit

$4.56M

+186.0%

Gross Margin

29.75%

N/A

Market Cap

$21.63M

N/A

Market Cap/Employee

$54.07K

N/A

Employees

400

N/A

Net Income

$122.41K

+106.4%

EBITDA

$1.28M

+652.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$2.73M

+155.7%

Accounts Receivable

$9.34M

+75.2%

Inventory

$146.20K

+30.5%

Long Term Debt

$13.94K

-93.5%

Short Term Debt

$552.38K

-48.7%

Return on Assets

-12.15%

N/A

Return on Invested Capital

0.42%

N/A

Free Cash Flow

$1.91M

+5313.7%

Operating Cash Flow

$2.06M

+71.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CBL.AXControl Bionics Limited
$0.06+0.00%
AGH.AXAlthea Group Holdings Limited
$0.02-4.76%
NC6.AXNanollose Limited
$0.08+0.00%
NTI.AXNeurotech International Limited
$0.01+7.69%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.32-0.01%
NOKNokia
$9.38-0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$48.98+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.45-0.05%

Questions About IME

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.